Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001

Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma

The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option

Intraventricular immunovirotherapy; a translational step forward

Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells

To be or not to be: the role of CD56 in multiple myeloma

Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met

Permeability and driving force: why is it difficult to control glycolytic flux by blocking lactate transporters?

Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells

The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)

Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6

Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?

The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation

Unveiling the non-canonical functions of EZH2 in prostate cancer

Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma

Addendum: Prognostic significance of isochromosome 17q in hematologic malignancies

Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability

Leakage? or Secretion? unconventional protein secretion in cancer

Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells

Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment

Mitochondria engage the integrated stress response to promote tumor growth

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types

Retraction: Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1

C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss

Correction: UBE2T knockdown inhibits gastric cancer progression

Proof-of-principle: targeted childhood leukemia prevention

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma

Cancer-associated fibroblasts: challenges and opportunities

Correction: Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer

Therapy drives genomic evolution in metastatic cancer

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior

Genetic modifiers of p53: opportunities for breast cancer therapies

Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma

Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?

Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells

p53 protects against formation of extrahepatic biliary precancerous lesions in the context of oncogenic Kras

Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors

Crosstalk between triple negative breast cancer and microenvironment

Retraction: Significance of B10 cell in patients with thymoma complicated with myasthenia gravis

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity

EGFR endocytosis: more than meets the eye

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850

Correction: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis

The nuclear envelope and metastasis

Adopted neoplastic cells and the consequences of their existence

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study

Crossroads: the role of biomarkers in the management of lumps in the breast

Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis

The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism

A balancing act: how whole-genome doubling and aneuploidy interact in human cancer

Systemic AL amyloidosis: current approach and future direction

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function

Retraction: Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1

Using cancer proteomics data to identify gene candidates for therapeutic targeting

From the groin to the brain: a transfemoral path to blood-brain barrier opening

Correction: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration

Targeting cellular respiration as a therapeutic strategy in glioblastoma

Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma

Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma

Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report

Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing

The molecular dialogue between the tumor cells and fibroblasts

Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide

Role of creatine shuttle in colorectal cancer cells

Addendum: Sustained response of three pediatric BRAF^V600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

Targeting the Src N-terminal regulatory element in cancer

Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer

Addendum: ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma

Retraction: Inhibition of microRNA-218 reduces HIF-1α by targeting on Robo1 in mice aortic endothelial cells under intermittent hypoxia

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression

Addendum: Laser speckle flowgraphy in juxtapapillary retinal capillary hemangioblastoma: a case report on natural course and therapeutic effect

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment

A macrophage is a macrophage is a macrophage—in metastasis

ACSL4: biomarker, mediator and target in quadruple negative breast cancer

ERβ as a mediator of estrogen signaling in inflammatory breast cancer

Retraction: MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1

Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?

LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair

The hope for targeting fatty acid binding proteins in multiple myeloma

Targeting GITR in cancer immunotherapy – there is no perfect knowledge

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Correction: iASPP overexpression is associated with clinical outcome in spinal chordoma and influences cellular proliferation, invasion, and sensitivity to cisplatin in vitro

Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

Addendum: Cerebral hemorrhage due to tuberculosis meningitis: a rare case report and literature review

The dark side of PLK1: Implications for cancer and genomic instability

Deciphering the mechanisms of action of progesterone in breast cancer

Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma

Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?

Targeting Ras with protein engineering

Transformation of immunosuppressive mtKRAS tumors into immunostimulatory tumors by Nerofe and Doxorubicin

Correction: Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?

Intrathoracic synovial sarcoma with BRAF V600E mutation

Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series

Multiclonality of ER expression in DCIS – Implications for clinical practice and future research

Addendum: Systemic AL amyloidosis: current approach and future direction

The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells

Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss

CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies

Addendum: Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series

Inhibition of glutamine metabolism: acting on tumoral cells or on tumor microenvironment?

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies

Predicting the molecular functions of regulatory genetic variants associated with cancer

Addendum: Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis

Retraction: The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma

Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis

Correction: Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway

Addendum: Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge

Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay

Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma

Correction: MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells

Addendum: Crosstalk between triple negative breast cancer and microenvironment

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma

Reassessing the risks and benefits of COVID-19 precautions in 2023

Correction: Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy

Addendum: The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option

Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas

Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma

Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells?

Correction: Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro

UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology

STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma

Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity

Retraction: Serum amyloid a induces M2b-like macrophage polarization during liver inflammation

Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer

Apoptotic cells may drive cell death in hair follicles during their regression cycle

GLS2 shapes ferroptosis in hepatocellular carcinoma

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

FAAH inhibition ameliorates breast cancer in a murine model

The double-edge sword of CRISPR application for in vivo studies

Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review

Retraction: Matrine alleviates lipopolysaccharide-induced intestinal inflammation and oxidative stress via CCR7 signal

Therapeutic potentials and challenges of cytostatic persister cancer cells

Addendum: Nasal NK/T cell lymphoma presents with long-term nasal blockage and fever: a rare case report and literature review

Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia

Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin

Correction: Abnormal topological organization in white matter structural networks in survivors of acute lymphoblastic leukaemia with chemotherapy treatment

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study

Melatonin and carcinogenesis in mice: the 50th anniversary of relationships

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability

Therapeutically harnessing cancer stem cell-derived exosomes

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies

Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine

One more step toward treatment of PARP inhibitor-resistant ovarian cancers